[Physiopathology, diagnosis and treatment of chronic myeloproliferative diseases: discussion]

Nihon Naika Gakkai Zasshi. 2007 Jul 10;96(7):1434-55. doi: 10.2169/naika.96.1434.
[Article in Japanese]
No abstract available

MeSH terms

  • Benzamides
  • Chronic Disease
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Myeloproliferative Disorders* / diagnosis
  • Myeloproliferative Disorders* / physiopathology
  • Myeloproliferative Disorders* / therapy
  • Piperazines / therapeutic use
  • Polycythemia Vera / diagnosis
  • Primary Myelofibrosis / therapy
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate